U.S. Construction Stock News

Argus recently downgraded Eversource Energy (ES) after a Federal Energy Regulatory Commission order reduced the utility's allowed return on electric transmission. This regulatory shift prompted revised earnings guidance and fresh questions about the stock's risk profile. See our latest analysis for Eversource Energy. Since the downgrade, Eversource Energy's share price has held around $71.71, with a 90 day share price return of 5.52%. Its 1 year total shareholder return of 20.06% suggests...

Markets are on alert as Washington circles the Federal Reserve, with talk of lighter regulation, a leaner balance sheet, and less policy guidance reshaping expectations for money, credit, and risk. High beta US stocks sit right in the blast zone of these potential shifts, reacting more sharply when financial conditions change. For investors, that can mean sharper swings in both directions, but also targeted opportunities when the policy story and company fundamentals line up. This article...

Private equity owners are pushing mid-market operators to prove that training actually improves field performance, not just compliance slide decks. That shift toward outcome focused, operationally embedded learning sits at the heart of the recent news driving this screener. For investors, the question is which mid-sized U.S. industrial and business services stocks are positioned to build real internal talent engines and which might struggle if expensive external learning platforms fall out of...

Recent analyst commentary around Onto Innovation (ONTO) has focused on strong demand for its Dragonfly G5 AI inspection platform and advanced packaging tools, drawing attention to where the stock currently trades. See our latest analysis for Onto Innovation. Recent price momentum has been strong, with Onto Innovation’s share price return of 22.88% over the past 30 days and 57.38% over 90 days, alongside a 1 year total shareholder return of 232.07%. This points to rising enthusiasm around its...

UMB Financial (UMBF) is back on investors’ radar after two related developments: a milestone of $250 billion in assets under custody in its Institutional Custody division and a new distributed ledger partnership at UMB Fund Services. See our latest analysis for UMB Financial. Those custody and distributed ledger updates arrive with UMB Financial’s stock already enjoying firm momentum, with a 26.77% 3 month share price return and a 39.86% 1 year total shareholder return suggesting investors...

The sudden halt to a bipartisan housing bill and rising political tension around the SAVE America Act have thrown fresh uncertainty over the housing market, from homebuilders to institutional owners of single family rentals. For investors, that kind of policy limbo can reshape risk and opportunity faster than earnings reports do. This article looks at how that news flows through to the Homebuilders & Residential Construction screener and what that could mean for your portfolio decisions...

Sify Technologies (NasdaqCM:SIFY) is in focus after securing a $71 million sustainability linked loan from the International Finance Corporation to help fund two new data centers in Navi Mumbai and Chennai. See our latest analysis for Sify Technologies. At a share price of $14.84, Sify Technologies has pulled back in the short term, with the 1 day, 7 day and 30 day share price returns all in decline. However, the 90 day share price return of 11.5%, year to date share price return of 20.8% and...

DaVita (DVA) moved back into focus after reporting first quarter 2026 results that exceeded expectations, lifting its earnings outlook and highlighting progress in its value-based Integrated Kidney Care platform expansion. See our latest analysis for DaVita. DaVita’s recent earnings beat and Integrated Kidney Care expansion come after a strong run, with the 90 day share price return of 35.90% and 1 year total shareholder return of 51.78% pointing to building momentum around the current...

The AI Infrastructure Stocks screener focuses on the hardware backbone that makes AI possible, at a time when global data, energy and inflation trends are front of mind for markets. With manufacturing PMIs firming in the US, services growth mixed in Europe and the UK, and central banks still wrestling with inflation, many investors are looking for business models tied to real assets and cash flow. This screener concentrates on companies that help build and run the specialized data centers,...

Why IDEAYA Biosciences Stock Is Back in Focus IDEAYA Biosciences (IDYA) is drawing renewed investor attention after enrolling the first patient in a Phase 1 trial that pairs IDE892 with IDE397 in MTAP-deleted solid tumors. The study centers on cancers such as non-small cell lung and pancreatic, where MTAP deletions are relatively common and no approved targeted therapies currently exist. This development is making IDEAYA Biosciences stock a focal point for investors watching early clinical...

Regulation is back in focus, and for many investors that can feel like a moving target. With new rules, shifting fiscal policy, changing interest rate expectations, and fresh economic data, some technology stocks appear better positioned than others to handle tighter oversight and evolving compliance demands. This Regulation-Resilient Technology Companies screener filters for large tech firms that already talk explicitly about regulation or compliance and that currently score well on measures...

General Motors (GM) stock is back in focus after the company moved beyond traditional auto manufacturing by agreeing to repurpose plants for defense production while ramping up energy storage, battery technology, and advanced driver assistance offerings. See our latest analysis for General Motors. At a share price of $78.95, General Motors has seen a 4.43% 90 day share price return and a 65.54% 1 year total shareholder return. This performance has coincided with growing attention on its...

Earlier in June 2026, HEICO Corporation amended its revolving credit agreement, lifting the facility to US$2.20 billion, extending its maturity to June 11, 2031, revising the rate structure to reflect HEICO’s long-term debt ratings, and releasing certain subsidiaries from guarantee obligations tied to both the credit facility and specific bond issues. The company also reported record fiscal second-quarter 2026 results and raised its semiannual cash dividend by 8% to US$0.13 per share,...

Atmos Energy stock reacts to recent performance data Atmos Energy (ATO) has drawn investor attention after recent performance figures highlighted a mix of share price moves and fundamental data, prompting closer scrutiny of how its gas distribution and pipeline operations align with current expectations. See our latest analysis for Atmos Energy. The recent 1 day share price return of 0.88% has not offset the 30 day share price decline of 2.94% and 90 day decline of 5.78%. However, longer term...

Belite Bio (BLTE) has drawn fresh attention after completing a rolling New Drug Application submission to the U.S. FDA for tinlarebant, a potential treatment for Stargardt disease type 1, alongside recent insider share sales. See our latest analysis for Belite Bio. Belite Bio's latest NDA milestone and insider transactions come after a mixed stretch of trading, with a 9.81% 1 month share price return and year to date share price performance that is down 5.34%. This sits alongside a very large...

Earlier this week, Toast reported year-on-year revenue growth of 21.9%, roughly matching analyst expectations, but significantly reduced its EBITDA guidance for the upcoming quarter. This mix of solid top-line expansion and weaker profitability outlook, paired with underperformance versus vertical software peers, has sharpened attention on Toast’s path to sustainable earnings. We’ll now examine how the sharp EBITDA guidance shortfall interacts with Toast’s AI-and-payments-led growth...

FIGS (FIGS) has recently drawn investor attention after its shares moved sharply, with the stock up 6.8% in the latest session but down over the past week and month. That short term volatility is prompting closer scrutiny. See our latest analysis for FIGS. Looking past the latest move, FIGS has a 1-year total shareholder return of 108.13% alongside a 90-day share price return that declined 23.66%. This suggests recent momentum has cooled after a strong longer term run as investors reassess...

Colgate-Palmolive (CL) is back on investor radars after recent trading data highlighted its share performance over the past month and past 3 months. This is prompting a closer look at what the current pricing might imply. See our latest analysis for Colgate-Palmolive. At a share price of $91.88, Colgate-Palmolive has recorded a 9.2% 3 month share price return and an 18.3% year to date share price return. The 3 year total shareholder return of 29.9% points to steady long term compounding and...

In recent days, Alkami Technology, Inc. highlighted the past success of its partnership with Landmark Credit Union, showing how Landmark accelerated its digital transformation and upgraded both retail and business member experiences using Alkami’s cloud-based platform. An important takeaway is that Landmark Credit Union scaled its commercial banking program using Alkami’s business and commercial capabilities, indicating how the platform can support deeper penetration into small-business and...

Guardant Health (GH) is back in focus after the U.S. Food and Drug Administration approved its Guardant360 CDx liquid biopsy as a companion diagnostic for Boehringer Ingelheim’s newly approved HERNEXEOS lung cancer therapy. See our latest analysis for Guardant Health. The recent FDA approval arrives as momentum in Guardant Health's stock has been strong, with a 90-day share price return of 55.58% and a 1-year total shareholder return of 174.69%. This indicates that investors are reassessing...

Kaspi.kz (NasdaqGS:KSPI) has drawn fresh attention after confirming a special cash dividend, with an ex dividend date tied to a payout of $1.74266 per share, together with a KZT 850 distribution per common share. See our latest analysis for Kaspi.kz. Against this backdrop, Kaspi.kz’s share price has moved to $86.0, with a 1 day share price return of 2.99% and a 7 day share price return of 3.28%. The 30 day share price return is down 6.05% and the 90 day share price return is 15.97%, alongside...

Shift4 Payments (FOUR) recently drew fresh attention after partnering with Lydian to let merchants accept Tether (USDT) while still settling in local currency, broadening its crypto offering alongside expectations for event driven payment volumes. See our latest analysis for Shift4 Payments. Despite the crypto partnership and expectations around event driven volumes, Shift4 Payments’ share price has been volatile, with a 1 day share price return of 14.35% and a year to date share price return...

Jiayin Group (NasdaqGM:JFIN) has wrapped up FY 2025 with fourth quarter revenue of C¥1,090.2 million and basic EPS of C¥1.95, alongside trailing 12 month revenue of C¥6.2 billion and EPS of C¥29.41, all against a backdrop of 45.4% trailing earnings growth over the past year. Over recent periods the company has seen quarterly revenue move from C¥1,404.5 million and EPS of C¥5.18 in Q4 2024 to C¥1,775.6 million and EPS of C¥10.11 in Q1 2025, before reaching the latest Q4 print. This sets the...

In June 2026, a Delaware jury found that Amgen and its subsidiary Teneobio willfully infringed Harbour BioMed’s Grosveld patent, awarding Harbour US$20,203,704 in damages and opening the door to a potential trebling of the award to about US$60.61 million. The verdict places fresh attention on Amgen’s exposure to intellectual property disputes around its antibody discovery technology, raising questions about legal risk management and potential future royalty or licensing obligations. We’ll...